Patent · US Active

Vaccine comprising Streptococcus pneumoniae capsular polysaccharide conjugates

US9610340B2 · kind B2 · utility

9Cited by

6References

16Claims

0Family size

Assignee

GLAXOSMITHKLINE BIOLOGICALS SA · BE

Inventors

Ralph Leon Biemans · Rixensart, BE
Nathalie Garcon · Rixensart, BE
Philippe Vincent Hermand · Rixensart, BE
Jan Poolman · Broek in Waterland, NL
Marcelle Paulette Van Mechelen · Rixensart, BE

Key dates

Filing date	Jun 24, 2008
Grant date	Apr 4, 2017
Priority date	—
Expiry date	Mar 15, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/70
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is in the field of pneumococcal capsular saccharide conjugate vaccines. Specifically, a multivalent Streptococcus pneumoniae immunogenic composition is provided with various conjugated capsular saccharides from different S. pneumoniae serotypes conjugated to 2 or more different carrier proteins, where the composition comprises serotype 19F capsular saccharide conjugated to diphtheria toxoid (DT) or CRM197, optionally wherein 19F is the only saccharide in the composition conjugated to diphtheria toxoid (DT) or CRM197.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.